Columbia Partners Investment Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$5.74M Sell
90,937
-14,061
-13% -$965K 2.23% 10
2018
Q3
$8.29M Hold
104,998
2.12% 9
2018
Q2
$6.28M Sell
104,998
-11,585
-10% -$623K 1.8% 14
2018
Q1
$4.7M Sell
116,583
-4,806
-4% -$234K 0.6% 47
2017
Q4
$6.38M Sell
121,389
-7,981
-6% -$426K 0.85% 27
2017
Q3
$6.09M Sell
129,370
-1,300
-1% -$52.3K 0.8% 29
2017
Q2
$4.62M Sell
130,670
-72,876
-36% -$2.25M 0.59% 49
2017
Q1
$4.81M Sell
203,546
-193,704
-49% -$3.84M 0.61% 45
2016
Q4
$5.31M Buy
397,250
+223,615
+129% +$3.61M 0.47% 74
2016
Q3
$3.22M Buy
+173,635
New +$3.06M 0.25% 133
2015
Q2
Sell
-36,500
Closed -$803K 337
2015
Q1
$803K Sell
36,500
-813
-2% -$20.6K 0.04% 271
2014
Q4
$1.02M Buy
+37,313
New +$908K 0.05% 272

Other funds holding EXAS

Columbia Partners Investment Management's EXAS Position: Q4 2018 in Review

Columbia Partners Investment Management reduced its Exact Sciences (EXAS) stake by 13% in Q4 2018, selling an estimated $965K and leaving 90,937 shares worth $5.74M. The position accounts for 2.23% of the portfolio, ranked #10.

Columbia Partners Investment Management first reported a position in EXAS in Q4 2014 and has held it in 12 quarters since. The position peaked at $8.29M in Q3 2018. 370 funds tracked by Wall St. Rank hold EXAS as of Q4 2018.

  • Columbia Partners Investment Management held 90,937 shares of Exact Sciences worth $5.74M as of Q4 2018.
  • Columbia Partners Investment Management sold 14,061 Exact Sciences shares in Q4 2018, an estimated $965K.
  • Exact Sciences made up 2.23% of Columbia Partners Investment Management's portfolio in Q4 2018, its #10 holding.
  • Columbia Partners Investment Management first reported a position in Exact Sciences in Q4 2014 and has held it in 12 quarters since.
  • Columbia Partners Investment Management's Exact Sciences position peaked at $8.29M in Q3 2018.
  • 370 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2018.

Based on Columbia Partners Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.